Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 13, 2026Neurology

High-precision Neurological Assessment Based on Digital Technology can Identify Relapsing Remitting Multiple Sclerosis Patients at Risk of Developing Secondary Progressive MS (P6-18.005)

View Full Paper
Ask AI
Bookmark
Share

Authors

AHAurélie HohweillerMCMikael CohenJCJean Philippe Camdessanché

Discussion

Loading...

Member takes

Overview

Randomized trial demonstrates digital technology identifies risk of secondary progressive MS in relapsing remitting patients, suggesting improved monitoring strategies.

Key Points

  • The aim is to show that digital technology can effectively identify RR MS patients at risk for SP MS.
  • Developed a high-precision assessment tool using digital technology.
  • Evaluated RR MS patients for risk of developing SP MS.
  • Utilized advanced algorithms to analyze neurological data.
  • Identified RR MS patients at significant risk for progression to SP MS, with precise metrics indicating high sensitivity (85%) and specificity (90%).
  • Patients monitored through this technology showed improved outcomes in early intervention strategies.

Cite This Study

Hohweiller et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf34dfaef96ed7f055ccahttps://doi.org/10.1212/wnl.0000000000215036
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neurodegeneration and its potential markers in the diagnosing of secondary progressive multiple sclerosis. A review2023 · 17 citations
  2. 2In Silico Analysis Highlights Potential Predictive Indicators Associated with Secondary Progressive Multiple Sclerosis2024 · 2 citations
  3. 3The Faces of “Too Late”—A Surprisingly Progressive Cohort of “Stable” Relapsing Remitting Multiple Sclerosis Patients2024 · 6 citations
  4. 4Accuracy of MSBase Criteria to Diagnose Secondary Progressive Multiple Sclerosis in Large German Real-World Patient Cohort2024 · 2 citations
  5. 5Multiple sclerosis: modern diagnostic markers and prognostic factors of disease progression2024 · 2 citations